Le Lézard
Classified in: Health
Subjects: LEG, WOM, STP, MAT

Asm. Autumn Burke's Bill Providing All Women A Choice for Their Maternity Care Clears Assembly Business & Professions Committee


SACRAMENTO, Calif., April 24, 2018 /PRNewswire/ -- Assemblywomen Autumn Burke's (D- Inglewood) bill, AB 2682, which would ensure all Californian pregnant women are able to access prenatal care of their choice passed out of the Assembly Business and Professions Committee today. The bill is now on the way to the Assembly Appropriations Committee.

Asm. Autumn Burke Logo (PRNewsfoto/California State Assemblymember)

Currently, Certified Nurse Midwives (CNM) can only practice under the supervision of a physician which can restrict the ability on where they could provide service. AB 2682 would untether a CNM from a doctor, in cases of normal childbirth, to provide care, including family planning, for the mother and the newborn.  AB 2682 also provides strong safeguards.  If at any time during the pregnancy, an abnormal condition would arise, the CNM would be required to refer or transfer care to a physician and follow the physician's treatment plan.

Although CNMs undergo more training than a Licensed Midwife, CNMs still have the requirement of being supervised by a doctor, while the Legislature removed physician supervision of Licensed Midwives in 2014.

California is one of only 6 states which places the physician requirement on CNMs, even though the doctor doesn't oversee health care delivery, inspect or review of charts, co-sign prescriptions, perform direct care on the patient, or evaluate CNM patients at any point during pregnancy.

"I have experienced first-hand the expert care provided by certified nurse midwives," explained Burke.  "I want all women in California to have the choice of selecting which kind of medical practitioner they would like to help them as they give birth to their children. Untethering CNMs from physician supervision requirements will increase access to health care services for thousands of women in both urban and rural areas," said Burke.

According to a national study published in February, areas within the U.S. where Certified Nurse Midwives are used for maternity care, pregnant mothers experience higher rates of spontaneous vaginal delivery, vaginal birth after cesarean, and breastfeeding, and significantly lower rates of cesarean, preterm birth, low birth weight infants, and neonatal death.  Furthermore, the use of Midwives in collaboration with other health care professionals drastically reduces the cost associated with maternity care.

 

SOURCE California State Assemblymember, Autumn Burke


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: